FindTrial
Sign In

Electrical Nerve Stimulation associated exercises in patients with low back pain

Low-frequency Transcutaneous Electrical Nerve Stimulation associated stabilization exercises in pain in patients with non-specific chronic low back pain: Randomized Clinical Trial - TENS - Transcutaneous Electrical Nerve Stimulation TENS - Transcutaneous Electrical Nerve Stimulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-86bzhkv
Enrollment
Unknown
Registered
2024-04-05
Start date
2024-07-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain

Interventions

This is a two-arm, double-blind, randomized controlled clinical trial. Two interventions will be carried out: low-frequency Transcutaneous Electrical Nerve Stimulation and abdominal strengthening exer
activation of transversus 3 x15 repetitions
unipodal support - 3 x15
bridge 3x15 repetitions
activation of erectors 3x 8-10 reps
plank 3x30 seconds plank
side 3x30 seconds
side leg 3x10-15 reps
spinal mobility exercise.) plus 30 of low Transcutaneous Electrical Nerve Stimulation with the following: frequency of 4 Hz, pulse duration of 240 µs and sufficient intensity to generate visible muscl
E05.723.402
E02.760.169.063.500.387

Sponsors

Universidade Federal do Rio Grande do Norte
Lead Sponsor
Universidade Federal do Rio Grande do Norte
Collaborator

Eligibility

Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Men and women; between 18 and 60 years of age; body mass index between 18.5 and 30 kg/m2; non-specific low back pain for at least 12 weeks and pain at least 3 on Visual Analog Scale - VAS; without prior contact with any electrotherapy current; absence of red flags such as - fracture, infection, tumor, inflammatory arthritis, pain with radicular characteristics, spondylolisthesis and spinal canal stenosis; without previous surgeries in the lumbar spine; no chronic use of analgesic opioids; no skin changes or changes in sensitivity at the application site; without pregnancy and pacemaker use

Exclusion criteria

Exclusion criteria: Participants who start using analgesics that modulate the primary outcome during treatment; accidents that prevent the exercise protocol; pregnanc; death and change of residence from the study state

Design outcomes

Primary

MeasureTime frame
Improvement in Pain, assessed using the sit-to-stand test (how much pain it felt when performing the movement) and the pressure algometer. Data collected before, after each session, after the protocol and 1 month after the end of the protocol.—

Secondary

MeasureTime frame
Decrease in Kinesiophobia, assessed by the TAMPA scale. Data will be evaluated before, after the end of treatment and 1 month after the end of treatment.;Improvement in Functional Capacity, assessed by the Roland-Morris questionnaire and functional sit-to-stand test. Data will be evaluated before, after the end of treatment and 1 month after the end of treatment.;Improved quality of life, assessed using the SF-36 questionnaire. Data will be evaluated before, after the end of treatment and 1 month after the end of treatment.;Decreased Fear, as assessed by the Fear Avoidance Beliefs Questionnaire. Data will be evaluated before, after the end of treatment and 1 month after the end of treatment.;Global perception of treatment will be assessed at the end of treatment.;Adherence will be evaluated at the end of treatment.—

Countries

Brazil

Contacts

Public ContactVinicius Caldas

Universidade Federal do Rio Grande do Norte

vvacfisio@gmail.com+55 (84) 3342-2018

Outcome results

None listed

Source: REBEC (via WHO ICTRP)